Getting it right for children: improving tuberculosis treatment access and new treatment options

References

• Graham SM, Sismanidis C, Menzies HJ, et al. Importance of tuberculosis to address child survival. Lancet 2014;383:1605-7
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Global Tuberculosis report 2014. Geneva: 2014. 978-92-4-156480-9
   Google Scholar
• Dodd P, Gardiner E, Coghlan R, Seddon J. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health 2014;2(8):e453-9
   PubMed Web of Science ®Google Scholar
• Jenkins HE, Tolman W, Yuen CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 2014;383(9928):1572-9
   PubMed Web of Science ®Google Scholar
• Roadmap for childhood tuberculosis. Towards zero deaths. WHO; 2013. ISBN 978 92 4 150613 7
   Google Scholar
• Jaganath D, Zalwango S, Okware B, et al. Contact investigation for active tuberculosis among child contacts in Uganda. Clin Infect Dis 2013;57(12):1685-92
   PubMed Web of Science ®Google Scholar
• Becerra MC, Swaminathan S. Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis. J Public Health Policy 2014;35(4):425-54
   PubMed Web of Science ®Google Scholar
• Roy A, Eisenhut M, Harris RJ, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ 2014;349:g4643
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Guidance for national tuberculosis programmes on the management of tuberculosis in children. WHO; 2014. ISBN: 978 92 4 154874 8
   Google Scholar
• Hesseling AC, Caldwell J, Cotton MF, et al. BCG vaccination in South African HIV-exposed infants – risks and benefits. S Afr Med J 2009;99(2):88-91
   PubMed Web of Science ®Google Scholar
• Tameris MD, Hatherill M, Landry BS, et al. MVA85A 020 Trial Study Team. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013;381:1021-8
   PubMed Web of Science ®Google Scholar
• McKenna L, Frick M, Seaworth B, Furin J. The “invisibility” of children with tuberculosis. J Public Health Policy 2015;36(1):123-5
   PubMed Web of Science ®Google Scholar
• Brewer TF. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 2000;31(Suppl 3):S64-7
   PubMed Web of Science ®Google Scholar
• Marais BJ, Ayles H, Graham SM, Godfrey-Faussett P. Screening and preventive therapy for TB. Clin Chest Med 2009;30:827-46
   PubMed Web of Science ®Google Scholar
• Cruz A, Ahmed A, Mandalakas A, Starke JR. Treatment of latent tuberculosis infection in children. J Pediatr Infect Dis Soc 2013;2:248-58
   PubMedGoogle Scholar
• World Health Organisation. Guidelines on the management of Latent TB infection. WHO, Geneva; 2015. ISBN: 978 92 4 154890 8
   Google Scholar
• Treatment Options for Latent TB infection factsheet. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of Tuberculosis Elimination. November 2011
   Google Scholar
• Triasih R, Robertson CF, Duke T, et al. A prospective evaluation of the symptom-based screening approach to the management of children who are contacts of tuberculosis cases. Clin Infect Dis 2015;60:12-18
   PubMed Web of Science ®Google Scholar
• Chan PC, Shinn-Forng Peng S, Chiou MY, et al. Risk for tuberculosis in child contacts. Development and validation of a predictive score. Am J Respir Crit Care Med 2014;189(2):203-13
   PubMedGoogle Scholar
• Seddon JA, Hesseling AC, Finlayson H, et al. Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study. Clin Infect Dis 2013;57(12):1676-84
   PubMed Web of Science ®Google Scholar
• Mandalakas AM, Hesseling AC, Gie RP, et al. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax 2013;68(3):247-55
   PubMed Web of Science ®Google Scholar
• Mandalakas AM, Detjen AK, Hessling AC, et al. Interferon-gamma release assays and childhood TB: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011;15:1018-32
   PubMed Web of Science ®Google Scholar
• Commercial serodiagnositic tests for diagnostic of tuberculosis: policy statement. WHO; Geneva: 2011
   Google Scholar
• Pearce EC, Woodward JF, Nyandiko WM, et al. A Systematic Review of Clinical Diagnostic Systems Used in the Diagnosis of Tuberculosis in Children. AIDS Res Treat 2012;2012:401896
   PubMedGoogle Scholar
• Desk-guide for diagnosis and management of TB in children. International Union Against Tuberculosis and Lung Disease; Paris: 2010
   Google Scholar
• Cuevas LE, Petrucci R, Swaminathan S. Tuberculosis diagnostics for children in high-burden countries: what is available and what is needed. Paediatr Int Child Health 2012;32(Suppl 2):S30-7
   PubMedGoogle Scholar
• Whittaker E, Zar HJ. Promising directions in the diagnosis of childhood tuberculosis. Expert Rev Respir Med 2012;6(4):385-95
   PubMed Web of Science ®Google Scholar
• Zar HJ, Workman L, Isaacs W, et al. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study. Lancet Glob Health 2013;1:e97-104
   PubMed Web of Science ®Google Scholar
• Scott LE, Beylis N, Nicol M, et al. The diagnostic accuracy of Xpert MTB/RIF on extra pulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South Africa. J Clin Microbiol 2014;52(6):1818-23
   PubMed Web of Science ®Google Scholar
• Cuevas L, Browning R, Bossuyt P, et al. Evaluation of tuberculosis diagnostics in children: 2. methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. J Infect Dis 2012;205(Suppl 2):S209-15
   PubMedGoogle Scholar
• Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med 2012;367(4):348-61
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Rapid advice: treatment of tuberculosis in children. Geneva: 2010. ISBN: 9789241500449
   Google Scholar
• McIlleron H, Willemse M, Werely CJ, et al. Isoniazid plasma concentrations in a cohort of children with TB: implications for international paediatric dosing guidelines. Clin Infect Dis 2009;48:1547-53
   PubMed Web of Science ®Google Scholar
• Thee S, Seddon JA, Donald PR, et al. Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations. Antimicrob Agents Chemother 2011;55:5560-7
   PubMed Web of Science ®Google Scholar
• Schaaf HS, Willemse M, Cilliers K, et al. Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of TB. BMC Med 2009;7:19-29
   PubMed Web of Science ®Google Scholar
• Thee S, Detjen A, Wahn U, Magdorf K. Pyrazinamide serum levels in childhood TB. Int J Tuberc Lung Dis 2008;12:1099-101
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Dosing instructions for the use of the currently available fixed dose combination TB medicines for children. WHO; Geneva: 2009
   Google Scholar
• Detjen AK, Macé C, Perrin C, et al. Adoption of revised dosage recommendations for childhood tuberculosis in countries with different childhood tuberculosis burdens. Public Health Action 2012;2(4):126-132(7)
   PubMedGoogle Scholar
• Out of Step. Deadly implementation gaps in the TB response. Medicins Sans Frontieres; 2014
   Google Scholar
• Graham S. Treatment of paediatric TB: revised WHO guidelines. Paediatr Respir Rev 2011;12:22-6
   PubMed Web of Science ®Google Scholar
• Marais BJ, Schaaf HS, Donald PR. Management of TB in children and new treatment options. Infect Disord Drug Targets 2011;11:144-56
   PubMedGoogle Scholar
• SHINE study: shorter treatment for minimal TB in children SHINE. ISRCTN63579542. Available from: http://apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN63579542 [Cited 26 November 2014]
   Google Scholar
• Ettehad D, Schaaf HS, Seddon JA, et al. Treatment outcomes for children with multi-drug resistant TB: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:449-56
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Guidelines for the programmatic management of drug-resistant TB, 2011 Update. WHO, Geneva; 2011
   Google Scholar
• Seddon JA, Thee S, Jacobs K, et al. Hearing loss in children treated for multidrug-resistant tuberculosis. J Infect 2013;66(4):320-9
   PubMed Web of Science ®Google Scholar
• Seddon JA, Hesseling AC, Willemse M, et al. Culture-confirmed MDR-TB in children: clinical features, treatment and outcome. Clin Infect Dis 2012;54:157-66
   PubMed Web of Science ®Google Scholar
• Thee S, Garcia-Prats AJ, Draper HR, et al. The pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis. Clin Infect Dis 2015;60(4):549-56
   PubMed Web of Science ®Google Scholar
• Hessling A. Pharmacokinetics of second line TB therapy in children. Tuberculosis treatment considerations for neonates and infants. Presentation at 43rd Union World Conference on Lung Health; 13 – 17 November 2012; Kuala Lumpur, Malaysia. Symposium 19 Available from: http://uwclh.conference2web.com/content/1894?from_view=all&view_address=sessions%3D380
   Google Scholar
• Second edition of management of multidrug-resistant tuberculosis in children: a field guide. The Sentinel Project for Pediatric Drug Resistant Tuberculosis; Boston, USA: 2014
   Google Scholar
• The use of Bedaquiline in the treatment of Multi-drug resistant TB. Interim Policy guidance. WHO; 2013
   Google Scholar
• The use of Delaminid in the treatment of Multi-drug resistant TB. Interim Policy guidance. WHO; 2014
   Google Scholar
• Esposito S, D’Ambrosio L, Tadolini M, et al. ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use. Eur Respir J 2014;44(3):811-15
   PubMed Web of Science ®Google Scholar
• Rich M. Meet the Expert Session. Management of Bedaquiline. Union conference, Paris 2013
   Google Scholar
• A 6-month safety, efficacy, and pharmacokinetic trial of delamanid in pediatric patients with multidrug resistant tuberculosis. Available from: http://clinicaltrials.gov/show/NCT01859923
   Google Scholar
• Hakin J. Delamanid use in Children: emerging perspectives on the treatment of MDR-TB in children. Presented at the 45th Union World Conference on Lung Health; 1 November 2014; Barcelona
   Google Scholar
• Nunn AJ, Rusen ID, Van Deun A, et al. Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial. Trials 2014;15:353
   Google Scholar
• Gillespie SH, Crook AM, McHugh TD, et al. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. N Engl J Med 2014;371(17):1577-87
   PubMed Web of Science ®Google Scholar
• Nachman S, Ahmed A, Amanullah F, et al. Towards earlier inclusion of Children in Tuberculosis drugs trials: Consensus statements from an Expert Panel. Lancet Infect Dis 2015; (In Press)
   PubMed Web of Science ®Google Scholar
• Venturini E, Turkova A, Chiappini E, et al. Tuberculosis and HIV co-infection in children. BMC Infect Dis 2014;14(Suppl 1):S5
   PubMed Web of Science ®Google Scholar
• Palme IB, Gudetta B, Bruchfeld J, et al. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J 2002;21:1053-61
   PubMed Web of Science ®Google Scholar
• Management of tuberculosis and HIV coinfection. Clinical Protocol for the WHO European Region. (2013 revision) WHO Euro Office, Geneva; 2013
   Google Scholar
• Jaganath D, Mupere E. Childhood tuberculosis and malnutrition. J Infect Dis 2012;206:1809-15
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Westra AE, Werschkull H, et al. Outcome of HIV infected children with culture confirmed tuberculosis. Arch Dis Child 2005;90(11):1171-4
   PubMed Web of Science ®Google Scholar
• Bhat PG, Kumar AM, Naik B, et al. Intensified tuberculosis case finding among malnourished children in nutritional rehabilitation centres of Karnataka, India: missed opportunities. PLoS One 2013;8(12):e84255
   PubMed Web of Science ®Google Scholar
• Chisti MJ, Ahmed T, Pietroni MAC, et al. Pulmonary tuberculosis in severely-malnourished or HIV-infected children with pneumonia: a review. J Health Popul Nutr 2013;31(3):308-13
   PubMed Web of Science ®Google Scholar
• Chisti MJ, Graham SM, Duke T, et al. A Prospective Study of the Prevalence of Tuberculosis and Bacteraemia in Bangladeshi Children with Severe Malnutrition and Pneumonia Including an Evaluation of Xpert MTB/RIF Assay. Plos One 2014;9(4):e93776
   PubMed Web of Science ®Google Scholar
• Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis – A critical review of the pre-chemotherapy literature. Int J Tuberc Lung Dis 2004;8:392-402
   PubMed Web of Science ®Google Scholar
• Graham SM, Triasih R. Editorial comment: more evidence to support screening of child contacts of tuberculosis: if not now, when? Clin Infect Dis 2013;57(12):1693-4
   PubMed Web of Science ®Google Scholar
• Portevin D, Moukambi F, Clowes P, et al. Performance of the novel TAM-TB assay to diagnose active tuberculosis in children: a prospective, multi-centre study. Lancet Infect Dis 2014;10:931-8
   Google Scholar
• Anderson ST, Kaforou M, Brent AJ, et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med 2014;370:1712-23
   PubMed Web of Science ®Google Scholar
• Updated from Out of the Dark, Meeting the needs of children with TB, MSF, November 2011
   Google Scholar
• Wright C. Fine needle aspiration biopsy of lymph nodes. CME 2012;30:56-60
   Google Scholar
• Fujita A, Murata K, Takamori M. Novel method for sputum induction using the Lung Flute in patients with suspected pulmonary tuberculosis. Respirology 2009;14(6):899-902
   PubMed Web of Science ®Google Scholar
• DR-TB drugs Under the Microscope. 3rd edition. MSF Access Campaign; 2013
   Google Scholar
• 2014 Pipeline report; HIV, HCV, and TB Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development. TAG, iBASE July 2014
   Google Scholar